4D-QSAR study of flavonoid derivatives with MCET method

Abstract

The Molecular Conformer Electron Topological (MCET) method was performed for the identification of the pharmacophore (Pha) group and predicting inhibitory activity of 42 flavonoid ligands on gamma-aminobutyric acid/benzodiazepine receptor complex (GABAA/BZR). In this method, Electron Topological Matrix (ETM) was used to visualize 3D structural descriptors. Multiple comparisons of ETM matrices for all flavonoid compounds allow us to define Pha-structure. Genetic algorithm (GA)- Partial Least-Squares (PLS) methods were performed to construct QSAR model and to select most important descriptors of the training set (32 compounds) and test set (10 compounds). The GA-PLS based model showed good results, q² = 0.808 and r²_test = 0.775 with high internal and external validation. The developed model can help to understand the inhibitory mechanism.

Keywords

• Flavonoid derivatives,GABAA,4D-QSAR,MCET

References

1. 1. Martens, S.; Mithöfer A. Phytochem. 2005, 66, 2399-2407.
2. 2. Harborne, J.B.; Williams C.A. Phytochem. 2000, 55, 481–504.
3. 3. Treutter, D. Environ. Chem. Lett. 2006, 4: 147–157.
4. 4. Medina, J.H.; Viola, H.; Wolfman, C.; Marder, M.; Wasowski, C.; Calvo, D. Paladini AC. Neurochem. Res. 1997, 22, 419-425.
5. 5. Marder, M.; Viola, H.; Wasowski, C.; Wolfman, C.; Waterman, P.G.; Cassels, B.K.; Medina, J.H.; Paladini, A.C. Biochem. Biophy. Res. Commun. 1996, 223, 384-389.
6. 6. Marder, M.; Zinczuk, J.; Colombo, M.I.; Wasowski, C.; Viola, H.; Wolfman, C.; Medina, J.H.; Ruveda, E.A.; Paladini, A.C. Bioorg. Med. Chem. Lett. 1997, 7, 2003-2008.
7. 7. Marder, M.; Viola, H.; Bacigaluppo, J.A.; Colombo, M.I.; Wasowski, C.; Wolfman, C.; Medina, J.H.; Ruveda, E.A.; Paladini, A.C. Biochem. Biophy. Res. Commun. 1998, 249, 481-485.
8. 8. Teuber, L.; Watjen, F.; Jensen, L.H. Curr. Pharm. Des. 1999, 5, 317- 343.

9. 9. Argyropoulos, S.V.; Nutt, D. Eur. Neuropsychopharharmacol. 1999, 6, 407-412.
10. 10. Tija, C.J.; Stephen, J.M.; Rachel, J. Nat. Rev. Neurosci. 2008, 9, 331-343.
11. 11. Amić, D.; Davidović-Amić, D.; Jurić, A.; Lučić, B.; Trinajstić, N. J. Chem. Inf. Comput. Sci. 1995, 35, 1034-1038.
12. 12. Costantino, L.; Rastelli, G.; Albasini, A. Eur. J. Med. Chem. 1996, 31, 693–699.
13. 13. Li, G.; Mian, Z.; Song, W.; Ai-Lin, L.; Guan-Hua, D. Bioorg. Med. Chem. Lett. 2011, 21, 5964-5970.
14. 14. Duchowicz, P.R.; Vitale, M.G.; Castro, E.A.; Autino, J.C.; Romanelli, G.P.; Bennardi, D.O. Eur. J. Med. Chem. 2008, 43, 1593-1602.
15. 15. Yilmaz, H.; Güzel, Y.; Önal, Z.; Altiparmak, G.; Özhan-Kocakaya, Ş. Bull. Korean Chem. Soc. 2012, 32, 4352-4360.
16. 16. Yilmaz, H.; Güzel, Y.; Boz, M.; Türkmenoğlu, B. Trop. J. Pharm. Res. 2014, 13,117-129.
17. 17. Hopfinger, A.J.; Wang, S.; Tokarski, J.S.; Jin, B.; Albuquerque, M.; Madhav, P.J.; Duraiswami, C. J Am Chem Soc. 1997, 119, 10509-10524.
18. 18. Hopfinger, A.J.; Reaka, A.; Venkatarangan, P.; Duca, J.S.; Wang, S. J. Chem Inf Comput Sci. 1999, 39: 1151-1160.
19. 19. Senese, C.L.; Duca, J.; Pan, D.; Hopfinger, A.J.; Tseng, Y.J. J. Chem. Inf. Comput. Sci. 2004, 44: 1526-1539.
20. 20. Huang, X.; Liu, T.; Gu, J.; Luo, X.; Ji, R.; Cao, Y.; Xue, H.; Wong, J.T.; Wong, B.L.; Pei, G.; Jiang, H.; Chen, K. J. Med. Chem. 2001, 44, 1883-1891.
21. 21. Bernardino, A.M.R.; Castro, H.C.; Frugulhetti, L.C. P.P.; Loureiro, N.I.V.; Azevedo, A.R.; Pinheiro, L.C.S.; Souza, T.M.L.; Giongo, V.; Passamani, F.; Magalhaes, U.O.; Albuquerque, M.G.; Cabral, L.M.; Rodrigues, C.R. Bioorg. Med. Chem. 2008, 16, 8670-8675.
22. 22. Bernardino, A.M.R.; Pinheiro, L.C.S.; Rodrigues, C.R.; Loureiro, N.I.V.; Castro, H.C.; Lanfredi-Rangel, A.; Sabatini-Lopes, J.; Borges, J.C.; Carvalho, J.M.; Romeiro, G.A.; Ferreira, V.F.; Frugulhetti, I.C.P.P.; Vannier-Santos, M.A. Bioorg. Med. Chem. 2006, 14, 5765-5770.
23. 23. Bharatam, P.V. Modeling and Informatics in Drug Design. Precilinical Development Handbook. 2008, 1-47.
24. 24. Hopfinger, A.J.; Wang, S.; Tokarski, J.S.; Jin, B.; Albuquerque, M.; Madhav, P.J.; Duraiswami, C. J. Am. Chem. Soc. 1997, 119, 10509-10524.
25. 25. Karelson, M.; Lobanov, V.S.; Katritzky, A.R. Chem. Rev. 1996, 96, 1027-1044.
26. 26. Bersuker, I. B.; Dimoglo, A.S. In Reviews in Computational Chemistry, Lipkowitz, K. B.，Boyd, D.B., Eds.; VCH: New York，NY, U.S.A., 1991; Vol 2, pp 423-460.
27. 27. Bersuker, I.B.; Dimoglo, A.S.; Yu, M.; Gorbachov, P.; Vlad, F.; Pesaro, M. New J. Chem. 1991, 15, 307-320.
28. 28. Dimoglo, A.S.; Beda, A.A.; Shvets, N.M.; Gorvachov, M.Y.; Kheifits, L.A.; Aulchenko, I.S. New. J. Chem. 1995, 19, 149-154.
29. 29. Guzel, Y.; Saripinar, E.; Yildirim, I. J. Mol. Struct. 1997, 418, 83-91.
30. 30. Guzel, Y.; Ozturk, E. Bioorg. Med. Chem. 2003, 11, 4383-4388.
31. 31. Bersuker, I.B. J Comput. Aided Mol. Des. 2008, 22, 423–430.
32. 32. Bersuker, I.B.; Bahceci, S.; Boggs, E.J. The Electron Conformational Method of Identification of Pharmacophore and Anti-Pharmacophore Shielding. In Pharmacophore Perception. Development, and Use in Drug Design. Guner OF., Ed.; International University Line: La Jolla, 2000, 457-474.
33. 33. Bersuker, I.B.; Bahceci, S.; Boggs, E.J.; Pearlman, R.S. J. Comput. Aided Mol. Des. 1999, 13, 419-434.
34. 34. Bersuker, I.B.; Bahceci, S.; Boggs, E.J.; Pearlman, R.S. EnViron. Res. 1999, 10, 157-173.